{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-082813","form_type":"8-K","ticker":"NWBO","cik":"0001072379","company_name":"NORTHWEST BIOTHERAPEUTICS INC","filed_at":"2022-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:54.888571+00:00","generated_at":"2026-06-24T08:33:20.305314+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"NWBO eliminates Series A/B Preferred, creates Series C Preferred (10M shares)","bullets":["Filed Certificate of Elimination for Series A and B Preferred Stock on July 20, 2022; no shares outstanding.","Created Series C Preferred Stock with 10M shares, $0.001 par value, rights and preferences established.","Series C created from authorized but unissued preferred shares; effective July 20, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-082813","json":"https://secwatch.observer/filing/0001104659-22-082813.json","markdown":"https://secwatch.observer/filing/0001104659-22-082813.md","text":"https://secwatch.observer/filing/0001104659-22-082813.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1072379/000110465922082813/0001104659-22-082813-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1072379/000110465922082813/tm2221829d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T08:33:20.305314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}